Huperzine A Oral Solution(Universal Pharmaceutical Group)

石杉碱甲口服溶液(万邦德制药)

Report date: 2025/07/04 14:09:41
NME

Base Information

Drug NameHuperzine A Oral Solution(Universal Pharmaceutical Group)
Drug Alias Name石杉碱甲口服溶液(2.2类改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank